ng-nitroarginine methyl ester has been researched along with Leukemia L 1210 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Giermasz, A; Gołab, J; Jakóbisiak, M; Jalili, A; Stokłosa, T; Zagozdzon, R | 1 |
1 other study(ies) available for ng-nitroarginine methyl ester and Leukemia L 1210
Article | Year |
---|---|
The potentiated antileukemic effects of doxorubicin and interleukin-12 combination are not dependent on nitric oxide production.
Topics: Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Crosses, Genetic; Doxorubicin; Drug Synergism; Enzyme Inhibitors; Female; Interleukin-12; Leukemia L1210; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Spleen; Survival Rate | 1999 |